Part of the color of podophyllin is due to the presence of a flavonoid-pigment called quercetin.67 Quercetin (3,31, 41, 5,7-pentahydroxy-flavone) occurring in conjugated forms in many plant products has been shown to be a highly mutagenic substance.8 In order further to characterize podophyllin we quantitatively estimated the content of quercetin and another mutagenic flavonoid kaempherol (3,4',5,7-tetrahydroxyflavone)9 in three batches of podophyllin 20%.
Podophyllin is a crude plant extract and is therefore not a well-defined product. It may contain variable amounts of the active lignan podophyllotoxin and the majority of the dry weight of podophyllin is made up of substances never identified. Objective-The purpose of the study was to estimate in podophyllin 20% the amounts of two mutagenic substances, quercetin and kaempherol. Methods-Using high-pressure liquid chromatography the amounts of quercetin and kaempherol were determined in 3 batches of podophyllin 20%. Results-Quercetin and kaempherol constitutes 2.5-3.8% and 6-0-6-4% of podophyllin dry substance, respectively. Podophyllotoxin constitutes in comparison 12*7-13.8% of podophyllin dry substance. An alternative to podophyllin is self-application of a purified podophyllotoxin 0.5% solution (Condyline, Condylox) .*6 Podophyllotoxin can be used in both women and men with externally located genital warts. '6 17 This topical preparation does not contain flavonoids and in the AMES test for mutagenesis, podophyllotoxin was found to be a nonmutagen. 18 In a mitotic chromosomal abberation test podophyllotoxin induced micronuclei in the bone marrow of mice (personal communication, Nycomed-DAK, Denmark)." This is not surprising as it is known that podophyllotoxin causes mitotic arrest, which is the basis of its therapeutic activity in genital warts. In addition prolonged topical application of podophyllotoxin is without carcinogenic activity in mice. '9 To replace podophyllin another approach could be the use of purified higher-concentrated solutions of podophyllotoxin. A 5% podophyllotoxin solution applied once weekly has been shown to be as effective and safe as podophyllin 20% in a controlled clinical trial in patients with genital warts.20 If a high-concentrated purified podophyllotoxin solution was developed and licensed it could with advantage replace the marketed podophyllin.
Conclusion

